We observed enhanced c-MET expression in T cells from patients with fibrosing conditions, mainly IPF and fibrotic HP, compared to CTD-ILD and non-fibrotic HP patients (Fig. 6A, B). This evidence concerns the gene MET and interstitial lung disease.